Modeling the impact of mitochondrial DNA damage in forebrain neurons and beyond

Mechanisms of Ageing and Development

Volumn 132, Issue 8-9, 2011, Pages 424-428

  Lauritzen, Knut H ^a   Dalhus, Bjørn ^a,b   Storm, Johan F ^c   Bjørås, Magnar ^a,b   Klungland, Arne ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Abasic sites; DNA repair; Forebrain neurons; Mitochondrial DNA damage; Mitochondrial dynamics

Indexed keywords

DOXORUBICIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PROTEIN MUTUNG1; THYMINE; UNCLASSIFIED DRUG; URACIL; URACIL DNA GLYCOSIDASE;

ARTICLE; BRAIN REGION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; ENZYME SPECIFICITY; FOREBRAIN; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HIPPOCAMPUS; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSGENE;

ANIMALS; DNA DAMAGE; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; GENOME, MITOCHONDRIAL; GENOMIC INSTABILITY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROSENCEPHALON; TUMOR SUPPRESSOR PROTEINS;

MUS; MUS MUSCULUS;

EID: 80053103354     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.02.006     Document Type: Article

References (30)

1. Baron U., Freundlieb S., Gossen M., Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 1995, 23:3605-3606.
2. Bulleit R.F., Bennett M.K., Molloy S.S., Hurley J.B., Kennedy M.B. Conserved and variable regions in the subunits of brain type II Ca2+/calmodulin-dependent protein kinase. Neuron 1988, 1:63-72.
3. Dianov G.L., Sleeth K.M., Dianova I.I., Allinson S.L. Repair of abasic sites in DNA. Mutat. Res. 2003, 531:157-163.
4. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5547-5551.
5. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
6. Gredilla R., Garm C., Holm R., Bohr V.A., Stevnsner T. Differential age-related changes in mitochondrial DNA repair activities in mouse brain regions. Neurobiol. Aging 2010, 31:993-1002.
7. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
8. Kavli B., Slupphaug G., Mol C.D., Arvai A.S., Peterson S.B., Tainer J.A., Krokan H.E. Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J. 1996, 15:3442-3447.
9. Lauritzen K.H., Moldestad O., Eide L., Carlsen H., Nesse G., Storm J.F., Mansuy I.M., Bergersen L.H., Klungland A. Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol. Cell Biol. 2010, 30:1357-1367.
10. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362:709-715.
11. Lauritzen K.H., Chang C., Wiksen H., Bergersen L.H., Klungland A., 2011, Mitochondrial DNA toxicity compromise mitochondrial dynamics and induces the hippocampal antioxidant defense, submitted for publication.
12. Lindeberg J., Mattsson R., Ebendal T. Timing the doxycycline yields different patterns of genomic recombination in brain neurons with a new inducible Cre transgene. J. Neurosci. Res. 2002, 68:248-253.
13. Mansuy I.M., Winder D.G., Moallem T.M., Osman M., Mayford M., Hawkins R.D., Kandel E.R. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 1998, 21:257-265.
14. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996, 274:1678-1683.
15. Michalon A., Koshibu K., Baumgartel K., Spirig D.H., Mansuy I.M. Inducible and neuron-specific gene expression in the adult mouse brain with the rtTA2S-M2 system. Genesis 2005, 43:205-212.
16. Morozov A., Kellendonk C., Simpson E., Tronche F. Using conditional mutagenesis to study the brain. Biol. Psychiatry 2003, 54:1125-1133.
17. Nilsen H., Otterlei M., Haug T., Solum K., Nagelhus T.A., Skorpen F., Krokan H.E. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 1997, 25:750-755.
18. Nilsen H., Steinsbekk K.S., Otterlei M., Slupphaug G., Aas P.A., Krokan H.E. Analysis of uracil-DNA glycosylases from the murine Ung gene reveals differential expression in tissues and in embryonic development and a subcellular sorting pattern that differs from the human homologues. Nucleic Acids Res. 2000, 28:2277-2285.
19. Otterlei M., Haug T., Nagelhus T.A., Slupphaug G., Lindmo T., Krokan H.E. Nuclear and mitochondrial splice forms of human uracil-DNA glycosylase contain a complex nuclear localisation signal and a strong classical mitochondrial localisation signal, respectively. Nucleic Acids Res. 1998, 26:4611-4617.
20. Pinz K.G., Shibutani S., Bogenhagen D.F. Action of mitochondrial DNA polymerase gamma at sites of base loss or oxidative damage. J. Biol. Chem. 1995, 270:9202-9206.
21. Slupphaug G., Markussen F.H., Olsen L.C., Aasland R., Aarsaether N., Bakke O., Krokan H.E., Helland D.E. Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene. Nucleic Acids Res. 1993, 21:2579-2584.
22. Slupphaug G., Mol C.D., Kavli B., Arvai A.S., Krokan H.E., Tainer J.A. A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature 1996, 384:87-92.
23. Sola C., Tusell J.M., Serratosa J. Comparative study of the distribution of calmodulin kinase II and calcineurin in the mouse brain. J. Neurosci. Res. 1999, 57:651-662.
24. Sun Y., Chen X., Xiao D. Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim. Biophys. Sin. (Shanghai) 2007, 39:235-246.
25. Tobimatsu T., Kameshita I., Fujisawa H. Molecular cloning of the cDNA encoding the third polypeptide (gamma) of brain calmodulin-dependent protein kinase II. J. Biol. Chem. 1988, 263:16082-16086.
26. Tyynismaa H., Suomalainen A. Mouse models of mitochondrial DNA defects and their relevance for human disease. EMBO Rep. 2009, 10:137-143.
27. Urlinger S., Baron U., Thellmann M., Hasan M.T., Bujard H., Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7963-7968.
28. Wallace D.C., Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 2009, 23:1714-1736.
29. Yamamoto A., Hen R., Dauer W.T. The ons and offs of inducible transgenic technology: a review. Neurobiol. Dis. 2001, 8:923-932.
30. Zhang H., Chatterjee A., Singh K.K. Saccharomyces cerevisiae polymerase zeta functions in mitochondria. Genetics 2006, 172:2683-2688.